Literature DB >> 3121543

Immunohistochemical detection of human epidermal growth factor in submandibular glands and their tumors using a polyclonal antiserum and a monoclonal antibody.

K Tsukitani1, Y Tatemoto, Y Noda, M Mori, T Hayashi, K Kato.   

Abstract

We applied immunohistochemical procedures to detect hEGF in salivary glands and pleomorphic adenomas of salivary-gland origin using a polyclonal hEGF antiserum and a monoclonal antibody against hEGF synthesized by applying the synthetic gene technique using Escherichia coli. In normal salivary glands, hEGF was mainly localized in the ductal system (i.e., intercalated, striated, and excretory ducts). The staining intensity and intracellular localization exhibited some variation depending on the fixative used. When a polyclonal hEGF antiserum was used for immunostaining, slight background staining was observed in sections prepared using the fixatives tested. Therefore, precise localization of hEGF was obtainable only in formalin-fixed sections using the monoclonal antibody against hEGF. In pleomorphic adenomas, positive hEGF staining was seen on the luminal side of tumors and in cells of ductal origin; no reactivity was present on the outer side of tumors or in cells of myoepithelial origin. Occasionally, long, spindle-shaped tumor cells and chondroidally changed tumor cells also exhibited positive staining for hEGF.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121543     DOI: 10.1007/bf00492581

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  20 in total

1.  Isolation and structure of urogastrone and its relationship to epidermal growth factor.

Authors:  H Gregory
Journal:  Nature       Date:  1975-09-25       Impact factor: 49.962

2.  Immunolocalization of keratins in salivary gland pleomorphic adenoma using monoclonal antibodies.

Authors:  M Mori; S Sumitomo; Y Iwai; M A Meenagham
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1986-06

3.  Radioimmunoassay of human epidermal growth factor (urogastrone).

Authors:  R H Starkey; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1977-12       Impact factor: 5.958

4.  Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy.

Authors:  E Tahara; H Sumiyoshi; J Hata; W Yasui; K Taniyama; T Hayashi; S Nagae; S Sakamoto
Journal:  Jpn J Cancer Res       Date:  1986-02

5.  Epidermal growth factor (urogastrone) in human fluids: size heterogeneity.

Authors:  Y Hirata; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1979-04       Impact factor: 5.958

6.  Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands.

Authors:  P U Heitz; M Kasper; S van Noorden; J M Polak; H Gregory; A G Pearse
Journal:  Gut       Date:  1978-05       Impact factor: 23.059

7.  Human epidermal growth factor/urogastrone: rapid purification procedure and partial characterization.

Authors:  C R Savage; R Harper
Journal:  Anal Biochem       Date:  1981-02       Impact factor: 3.365

8.  Immunohistochemical localization of epidermal growth factor in rat and man.

Authors:  S S Poulsen; E Nexø; P S Olsen; J Hess; P Kirkegaard
Journal:  Histochemistry       Date:  1986

9.  Synthesis and secretion of human epidermal growth factor by Escherichia coli.

Authors:  T Oka; S Sakamoto; K Miyoshi; T Fuwa; K Yoda; M Yamasaki; G Tamura; T Miyake
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Synthesis and secretion of an epidermal growth factor (EGF) by human fibroblast cells in culture.

Authors:  M Kurobe; S Furukawa; K Hayashi
Journal:  Biochem Biophys Res Commun       Date:  1985-09-30       Impact factor: 3.575

View more
  8 in total

1.  Immunohistochemical distribution of human epidermal growth factor in salivary gland tumours.

Authors:  M Mori; R Naito; K Tsukitani; Y Okada; T Hayashi; K Kato
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

2.  The correlation of epidermal growth factor with invasion and metastasis in human gastric cancer.

Authors:  M Onda; A Tokunaga; K Nishi; T Yoshiyuki; Y Shimizu; T Kiyama; T Mizutani; N Matsukura; N Tanaka; K Yamashita
Journal:  Jpn J Surg       Date:  1990-05

3.  Expression of human epidermal growth factor and its receptor in esophageal cancer.

Authors:  H Mukaida; T Yamamoto; T Hirai; M Toi; T Nakamura; T Wada; Y Yamashita; K Kawano; M Niimoto
Journal:  Jpn J Surg       Date:  1990-05

4.  Immunohistochemical expression of epidermal growth factor receptor in salivary gland tumours.

Authors:  K Yamada; K Iwai; Y Okada; M Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21.

Authors:  Y Hayashi; N Ishii; C Obayashi; K Jinnai; K Hanioka; Y Imai; H Itoh
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Secretion of protein and epidermal growth factor (EGF) by transplanted human pancreas.

Authors:  J W Konturek; M Buesing; U T Hopt; J Stachura; H D Becker; S J Konturek
Journal:  Int J Pancreatol       Date:  1992-08

7.  Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia.

Authors:  S Tanaka; K Imanishi; M Yoshihara; K Haruma; K Sumii; G Kajiyama; S Akamatsu
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

8.  Prognostic value of expression of molecular markers in adenoid cystic cancer of the salivary glands compared with lymph node metastasis: a retrospective study.

Authors:  Seok Ki Lee; Min Su Kwon; Yoon Se Lee; Seung-Ho Choi; Sang Yoon Kim; Kyoung Ja Cho; Soon Yuhl Nam
Journal:  World J Surg Oncol       Date:  2012-12-11       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.